|
Michael SmithFinancial Review |
The value of West Australian nerve repair biotech Orthocell has doubled since September as it beefs up its shareholder bases and prepares to break...
They’re under fire from parliamentarians and hospitals for making too much profit, and yet are caught in a customer land grab that is shaving...